Pfizer announced the introduction of 3 new oncology biosimilars to the US market at a substantially discounted price.
Non Hodgkin Lymphoma
The role pharmacists have in helping cancer patients.
Non-Hodgkin’s lymphoma rates are increasing, so how can pharmacists help?
Why research says understanding the overlap between Kaposi sarcoma-associated herpesvirus (KSHV) and human herpesvirus 8 (HHV8)-positive large B-cell lymphomas and associated diseases may lead to better outcomes.
New research indicates lower survival in patients with slower gait speed.
A look at incidence rates, survival rates, and more.
Immunotransplants May Enhance Efficacy of Checkpoint Blockade Immunotherapy for Treating Resistant Lymphomas
Immunotherapy drugs combined with stem cell transplantation.
A look at a new study examining the effects of a pipeline drug.
Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.
The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.